Denmark Pharmaceuticals and Healthcare Market: New market analysis published

Pricing regulations in Denmark reflect the broader trend being felt across the European region.

However, analysts believe Denmark´s expanding and ageing population will be a significant factor, ensuring that demand for healthcare remains high. The government will inevitably need to adopt strategies and cost efficiencies to address increasing healthcare costs.

Headline Expenditure Projections:

- Pharmaceuticals: DKK20.48bn (US$3.54bn) in 2012 to DKK20.20bn (US$3.61bn) in 2013; -1.4% in local currency terms and 1.9% in US dollar terms. Forecast slightly down compared with Q413 due to macroeconomic effects.

- Healthcare: DKK202.99bn (US$35.06bn) in 2012 to DKK207.88bn (US$37.10bn) in 2013; +2.4% in local currency terms and +5.8% in US dollar terms. Forecast slightly down compared with Q413 due to macroeconomic effects.

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Disclaimer:
If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.